Shopping Cart 0
Cart Subtotal
USD 0

Asia Pacific Autoimmune Disease Diagnostics Market 2021-2031 by Product (Assay Kits & Consumables, Analyzers & Instruments), Test Type (Autoantibodies and Immunologic, Inflammatory Marker, Routine Laboratory, Others), Disease Type (Systemic, Localized), Gender (Female, Male), Age (<44, 44-64, >64), End User (Hospitals, Clinics, Diagnostic Labs), and Country: Trend Forecast and Growth Opportunity

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
USD 2600

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
USD 4000

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
USD 5500

Details

Asia Pacific autoimmune disease diagnostics market will grow by 9.7% annually with a total addressable market cap of USD 19.06 billion over 2022-2031 owing to the growing prevalence of autoimmune diseases, the strong investment in research and development activities, the rise in technological advancements, increasing patient awareness and healthcare expenditure, and favorable government policies.

Highlighted with 35 tables and 70 figures, this 131-page report Asia Pacific Autoimmune Disease Diagnostics Market 2021-2031 by Product (Assay Kits & Consumables, Analyzers & Instruments), Test Type (Autoantibodies and Immunologic, Inflammatory Marker, Routine Laboratory, Others), Disease Type (Systemic, Localized), Gender (Female, Male), Age (<44, 44-64, >64), End User (Hospitals, Clinics, Diagnostic Labs), and Country: Trend Forecast and Growth Opportunity is based on a comprehensive research of the entire Asia Pacific autoimmune disease diagnostics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:

Market Structure

Growth Drivers

Restraints and Challenges

Emerging Product Trends & Market Opportunities

Porter's Fiver Forces

The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Asia Pacific autoimmune disease diagnostics market in every aspect of the classification from perspectives of Product, Test Type, Disease Type, Gender, Age, End User, and Country.

Based on Product, the Asia Pacific market is segmented into the following sub-markets with annual revenue (USD mn) for 2021-2031 included in each section.

Assay Kits & Consumables

Analyzers & Instruments

Based on Test Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue (USD mn) for 2021-2031 included in each section.

Autoantibodies and Immunologic Tests

o Antinuclear Antibody Tests

o Anti-cyclic Citrullinated Peptide

o Enzyme-Linked Immunosorbent Assay (ELISA)

o Rheumatoid Factor

o Thyroid Antibody Tests

o Other Autoantibodies and Immunologic Tests

Inflammatory Marker Tests

o C-Reactive Protein (CRP)

o Erythrocyte Sedimentation Rate (ESR)

o Other Inflammatory Marker Tests

Routine Laboratory Tests

o Urinalysis

o Complete Blood Count (CBC) Tests

o Other Routine Laboratory Tests

Other Test Types

Based on Disease Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue (USD mn) for 2021-2031 included in each section.

Systemic Autoimmune Disease

o Rheumatoid Arthritis

o Systemic Lupus Erythematosus (SLE)

o Psoriasis/Psoriatic Arthritis

o Other Systemic Autoimmune Diseases

Localized Autoimmune Disease

o Thyroiditis

o Multiple Sclerosis

o Inflammatory Bowel Disease

o Type 1 Diabetes

o Other Localized Autoimmune Diseases

Based on Gender, the Asia Pacific market is segmented into the following sub-markets with annual revenue (USD mn) for 2021-2031 included in each section.

Female Patients

Male Patients

Based on Age, the Asia Pacific market is segmented into the following sub-markets with annual revenue (USD mn) for 2021-2031 included in each section.

< 44

44 - 64

> 64

Based on End User, the Asia Pacific market is segmented into the following sub-markets with annual revenue (USD mn) for 2021-2031 included in each section.

Hospitals

Clinics

Diagnostic Labs

Other End Users

Geographically, the following national/local markets are fully investigated:

Japan

China

South Korea

Australia

India

Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)

For each key country, detailed analysis and data for annual revenue (USD mn) are available for 2021-2031. The breakdown of the regional market by country and split of key national markets by Product, Disease Type, and End User over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Selected Key Players:

Abbott Laboratories

Beckman Coulter, Inc.

Biomerieux SA

Bio-rad Laboratories Inc.

F. Hoffmann-la Roche Ltd.

Hemagen Diagnostics Inc.

Myriad Genetics Inc.

PerkinElmer Inc. (Euroimmun AG)

Quest Diagnostics Inc.

Siemens Healthineers Inc.

Thermo Fisher Scientific Inc.

Trinity Biotech PLC

Werfen Company (Inova Diagnostics Inc.)

(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

READ MORE

Table Of Content

Scope

1 Introduction 8

1.1 Industry Definition and Research Scope 8

1.1.1 Industry Definition 8

1.1.2 Research Scope 9

1.2 Research Methodology 12

1.2.1 Overview of Market Research Methodology 12

1.2.2 Market Assumption 13

1.2.3 Secondary Data 13

1.2.4 Primary Data 13

1.2.5 Data Filtration and Model Design 14

1.2.6 Market Size/Share Estimation 15

1.2.7 Research Limitations 16

1.3 Executive Summary 17

2 Market Overview and Dynamics 20

2.1 Market Size and Forecast 20

2.1.1 Impact of COVID-19 on World Economy 21

2.1.2 Impact of COVID-19 on the Market 23

2.2 Major Growth Drivers 25

2.3 Market Restraints and Challenges 30

2.4 Emerging Opportunities and Market Trends 33

2.5 Porter's Fiver Forces Analysis 37

3 Segmentation of Asia Pacific Market by Product 42

3.1 Market Overview by Product 42

3.2 Assay Kits & Consumables 44

3.3 Analyzers & Instruments 45

4 Segmentation of Asia Pacific Market by Test Type 46

4.1 Market Overview by Test Type 46

4.2 Autoantibodies and Immunologic Tests 48

4.2.1 Antinuclear Antibody Tests 50

4.2.2 Anti-cyclic Citrullinated Peptide 51

4.2.3 Enzyme-Linked Immunosorbent Assay (ELISA) 52

4.2.4 Rheumatoid Factor 53

4.2.5 Thyroid Antibody Tests 54

4.2.6 Other Autoantibodies and Immunologic Tests 55

4.3 Inflammatory Marker Tests 56

4.3.1 C-Reactive Protein (CRP) 58

4.3.2 Erythrocyte Sedimentation Rate (ESR) 59

4.3.3 Other Inflammatory Marker Tests 60

4.4 Routine Laboratory Tests 61

4.4.1 Urinalysis 63

4.4.2 Complete Blood Count (CBC) Tests 64

4.4.3 Other Routine Laboratory Tests 65

4.5 Other Test Types 66

5 Segmentation of Asia Pacific Market by Disease Type 67

5.1 Market Overview by Disease Type 67

5.2 Systemic Autoimmune Disease 69

5.2.1 Rheumatoid Arthritis 71

5.2.2 Systemic Lupus Erythematosus (SLE) 72

5.2.3 Psoriasis/Psoriatic Arthritis 73

5.2.4 Other Systemic Autoimmune Diseases 74

5.3 Localized Autoimmune Disease 75

5.3.1 Thyroiditis 77

5.3.2 Multiple Sclerosis 78

5.3.3 Inflammatory Bowel Disease 79

5.3.4 Type 1 Diabetes 80

5.3.5 Other Localized Autoimmune Diseases 81

6 Segmentation of Asia Pacific Market by Gender 82

6.1 Market Overview by Gender 82

6.2 Female Patients 84

6.3 Male Patients 85

7 Segmentation of Asia Pacific Market by Age 86

7.1 Market Overview by Age 86

7.2 < 44 88

7.3 44 - 64 89

7.4 > 64 90

8 Segmentation of Asia Pacific Market by End User 91

8.1 Market Overview by End User 91

8.2 Hospitals 93

8.3 Clinics 94

8.4 Diagnostic Labs 95

8.5 Other End Users 96

9 Asia-Pacific Market 2021-2031 by Country 97

9.1 Overview of Asia-Pacific Market 97

9.2 Japan 100

9.3 China 103

9.4 Australia 105

9.5 India 107

9.6 South Korea 109

9.7 Rest of APAC Region 111

10 Competitive Landscape 113

10.1 Overview of Key Vendors 113

10.2 New Product Launch, Partnership, Investment, and M&A 116

10.3 Company Profiles 117

Abbott Laboratories 117

Beckman Coulter, Inc. 119

Biomerieux SA 120

Bio-rad Laboratories Inc. 121

F. Hoffmann-la Roche Ltd. 122

Hemagen Diagnostics Inc. 123

Myriad Genetics Inc. 124

PerkinElmer Inc. (Euroimmun AG) 125

Quest Diagnostics Inc. 126

Siemens Healthineers Inc. 127

Thermo Fisher Scientific Inc. 128

Trinity Biotech PLC 129

Werfen Company (Inova Diagnostics Inc.) 130

RELATED REPORTS 131


List Of Figure

List of Figures:

Figure 1. Research Method Flow Chart 12

Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 15

Figure 3. Asia Pacific Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031 17

Figure 4. Asia Pacific Autoimmune Disease Diagnostics Market, 2021-2031, USD mn 20

Figure 5. Impact of COVID-19 on Business 23

Figure 6. Primary Drivers and Impact Factors of Asia Pacific Autoimmune Disease Diagnostics Market 25

Figure 7. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 28

Figure 8. World Population 65 and Over, % of Total Population, 1950-2060 28

Figure 9. Primary Restraints and Impact Factors of Asia Pacific Autoimmune Disease Diagnostics Market 30

Figure 10. Investment Opportunity Analysis 34

Figure 11. Porter's Fiver Forces Analysis of Asia Pacific Autoimmune Disease Diagnostics Market 37

Figure 12. Breakdown of Asia Pacific Autoimmune Disease Diagnostics Market by Product, 2021-2031, % of Revenue 43

Figure 13. Asia Pacific Addressable Market Cap in 2022-2031 by Product, Value (USD mn) and Share (%) 43

Figure 14. Asia Pacific Autoimmune Disease Diagnostics Market by Product: Assay Kits & Consumables, 2021-2031, USD mn 44

Figure 15. Asia Pacific Autoimmune Disease Diagnostics Market by Product: Analyzers & Instruments, 2021-2031, USD mn 45

Figure 16. Breakdown of Asia Pacific Autoimmune Disease Diagnostics Market by Test Type, 2021-2031, % of Sales Revenue 47

Figure 17. Asia Pacific Addressable Market Cap in 2022-2031 by Test Type, Value (USD mn) and Share (%) 47

Figure 18. Asia Pacific Autoimmune Disease Diagnostics Market by Test Type: Autoantibodies and Immunologic Tests, 2021-2031, USD mn 48

Figure 19. Asia Pacific Autoimmune Disease Diagnostics Market by Autoantibodies and Immunologic Tests: Antinuclear Antibody Tests, 2021-2031, USD mn 50

Figure 20. Asia Pacific Autoimmune Disease Diagnostics Market by Autoantibodies and Immunologic Tests: Anti-cyclic Citrullinated Peptide, 2021-2031, USD mn 51

Figure 21. Asia Pacific Autoimmune Disease Diagnostics Market by Autoantibodies and Immunologic Tests: Enzyme-Linked Immunosorbent Assay (ELISA), 2021-2031, USD mn 52

Figure 22. Asia Pacific Autoimmune Disease Diagnostics Market by Autoantibodies and Immunologic Tests: Rheumatoid Factor, 2021-2031, USD mn 53

Figure 23. Asia Pacific Autoimmune Disease Diagnostics Market by Autoantibodies and Immunologic Tests: Thyroid Antibody Tests, 2021-2031, USD mn 54

Figure 24. Asia Pacific Autoimmune Disease Diagnostics Market by Autoantibodies and Immunologic Tests: Other Autoantibodies and Immunologic Tests, 2021-2031, USD mn 55

Figure 25. Asia Pacific Autoimmune Disease Diagnostics Market by Test Type: Inflammatory Marker Tests, 2021-2031, USD mn 56

Figure 26. Asia Pacific Autoimmune Disease Diagnostics Market by Inflammatory Marker Tests: C-Reactive Protein (CRP), 2021-2031, USD mn 58

Figure 27. Asia Pacific Autoimmune Disease Diagnostics Market by Inflammatory Marker Tests: Erythrocyte Sedimentation Rate (ESR), 2021-2031, USD mn 59

Figure 28. Asia Pacific Autoimmune Disease Diagnostics Market by Inflammatory Marker Tests: Other Inflammatory Marker Tests, 2021-2031, USD mn 60

Figure 29. Asia Pacific Autoimmune Disease Diagnostics Market by Test Type: Routine Laboratory Tests, 2021-2031, USD mn 61

Figure 30. Asia Pacific Autoimmune Disease Diagnostics Market by Routine Laboratory Tests: Urinalysis, 2021-2031, USD mn 63

Figure 31. Asia Pacific Autoimmune Disease Diagnostics Market by Routine Laboratory Tests: Complete Blood Count (CBC) Tests, 2021-2031, USD mn 64

Figure 32. Asia Pacific Autoimmune Disease Diagnostics Market by Routine Laboratory Tests: Other Routine Laboratory Tests, 2021-2031, USD mn 65

Figure 33. Asia Pacific Autoimmune Disease Diagnostics Market by Test Type: Other Test Types, 2021-2031, USD mn 66

Figure 34. Breakdown of Asia Pacific Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, % of Sales Revenue 68

Figure 35. Asia Pacific Addressable Market Cap in 2022-2031 by Disease Type, Value (USD mn) and Share (%) 68

Figure 36. Asia Pacific Autoimmune Disease Diagnostics Market by Disease Type: Systemic Autoimmune Disease, 2021-2031, USD mn 69

Figure 37. Asia Pacific Autoimmune Disease Diagnostics Market by Systemic Autoimmune Disease: Rheumatoid Arthritis, 2021-2031, USD mn 71

Figure 38. Asia Pacific Autoimmune Disease Diagnostics Market by Systemic Autoimmune Disease: Systemic Lupus Erythematosus (SLE), 2021-2031, USD mn 72

Figure 39. Asia Pacific Autoimmune Disease Diagnostics Market by Systemic Autoimmune Disease: Psoriasis/Psoriatic Arthritis, 2021-2031, USD mn 73

Figure 40. Asia Pacific Autoimmune Disease Diagnostics Market by Systemic Autoimmune Disease: Other Systemic Autoimmune Diseases, 2021-2031, USD mn 74

Figure 41. Asia Pacific Autoimmune Disease Diagnostics Market by Disease Type: Localized Autoimmune Disease, 2021-2031, USD mn 75

Figure 42. Asia Pacific Autoimmune Disease Diagnostics Market by Localized Autoimmune Disease: Thyroiditis, 2021-2031, USD mn 77

Figure 43. Asia Pacific Autoimmune Disease Diagnostics Market by Localized Autoimmune Disease: Multiple Sclerosis, 2021-2031, USD mn 78

Figure 44. Asia Pacific Autoimmune Disease Diagnostics Market by Localized Autoimmune Disease: Inflammatory Bowel Disease, 2021-2031, USD mn 79

Figure 45. Asia Pacific Autoimmune Disease Diagnostics Market by Localized Autoimmune Disease: Type 1 Diabetes, 2021-2031, USD mn 80

Figure 46. Asia Pacific Autoimmune Disease Diagnostics Market by Localized Autoimmune Disease: Other Localized Autoimmune Diseases, 2021-2031, USD mn 81

Figure 47. Breakdown of Asia Pacific Autoimmune Disease Diagnostics Market by Gender, 2021-2031, % of Revenue 83

Figure 48. Asia Pacific Addressable Market Cap in 2022-2031 by Gender, Value (USD mn) and Share (%) 83

Figure 49. Asia Pacific Autoimmune Disease Diagnostics Market by Gender: Female Patients, 2021-2031, USD mn 84

Figure 50. Asia Pacific Autoimmune Disease Diagnostics Market by Gender: Male Patients, 2021-2031, USD mn 85

Figure 51. Breakdown of Asia Pacific Autoimmune Disease Diagnostics Market by Age, 2021-2031, % of Revenue 87

Figure 52. Asia Pacific Addressable Market Cap in 2022-2031 by Age, Value (USD mn) and Share (%) 87

Figure 53. Asia Pacific Autoimmune Disease Diagnostics Market by Age: < 44, 2021-2031, USD mn 88

Figure 54. Asia Pacific Autoimmune Disease Diagnostics Market by Age: 44 - 64, 2021-2031, USD mn 89

Figure 55. Asia Pacific Autoimmune Disease Diagnostics Market by Age: > 64, 2021-2031, USD mn 90

Figure 56. Breakdown of Asia Pacific Autoimmune Disease Diagnostics Market by End User, 2021-2031, % of Revenue 91

Figure 57. Asia Pacific Addressable Market Cap in 2022-2031 by End User, Value (USD mn) and Share (%) 92

Figure 58. Asia Pacific Autoimmune Disease Diagnostics Market by End User: Hospitals, 2021-2031, USD mn 93

Figure 59. Asia Pacific Autoimmune Disease Diagnostics Market by End User: Clinics, 2021-2031, USD mn 94

Figure 60. Asia Pacific Autoimmune Disease Diagnostics Market by End User: Diagnostic Labs, 2021-2031, USD mn 95

Figure 61. Asia Pacific Autoimmune Disease Diagnostics Market by End User: Other End Users, 2021-2031, USD mn 96

Figure 62. Breakdown of APAC Autoimmune Disease Diagnostics Market by Country, 2021 and 2031, % of Revenue 98

Figure 63. Contribution to APAC 2022-2031 Cumulative Market by Country, Value (USD mn) and Share (%) 99

Figure 64. Autoimmune Disease Diagnostics Market in Japan, 2021-2031, USD mn 101

Figure 65. Autoimmune Disease Diagnostics Market in China, 2021-2031, USD mn 103

Figure 66. Autoimmune Disease Diagnostics Market in Australia, 2021-2031, USD mn 105

Figure 67. Autoimmune Disease Diagnostics Market in India, 2021-2031, USD mn 107

Figure 68. Autoimmune Disease Diagnostics Market in South Korea, 2021-2031, USD mn 109

Figure 69. Autoimmune Disease Diagnostics Market in Rest of APAC, 2021-2031, USD mn 111

Figure 70. Growth Stage of Asia Pacific Autoimmune Disease Diagnostics Industry over the Forecast Period 113


List Of Table

List of Tables:

Table 1. Snapshot of Asia Pacific Autoimmune Disease Diagnostics Market in Balanced Perspective, 2021-2031 18

Table 2. World Economic Outlook, 2021-2031 22

Table 3. World Health Spending by Region, USD bn, 2013-2020 29

Table 4. Main Product Trends and Market Opportunities in Asia Pacific Autoimmune Disease Diagnostics Market 33

Table 5. Asia Pacific Autoimmune Disease Diagnostics Market by Product, 2021-2031, USD mn 42

Table 6. Asia Pacific Autoimmune Disease Diagnostics Market by Test Type, 2021-2031, USD mn 46

Table 7. Asia Pacific Autoimmune Disease Diagnostics Market: Autoantibodies and Immunologic Tests by Type, 2021-2031, USD mn 49

Table 8. Asia Pacific Autoimmune Disease Diagnostics Market: Inflammatory Marker Tests by Type, 2021-2031, USD mn 57

Table 9. Asia Pacific Autoimmune Disease Diagnostics Market: Routine Laboratory Tests by Type, 2021-2031, USD mn 62

Table 10. Asia Pacific Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, USD mn 67

Table 11. Asia Pacific Autoimmune Disease Diagnostics Market: Systemic Autoimmune Disease by Type, 2021-2031, USD mn 70

Table 12. Asia Pacific Autoimmune Disease Diagnostics Market: Localized Autoimmune Disease by Type, 2021-2031, USD mn 76

Table 13. Asia Pacific Autoimmune Disease Diagnostics Market by Gender, 2021-2031, USD mn 82

Table 14. Asia Pacific Autoimmune Disease Diagnostics Market by Age, 2021-2031, USD mn 86

Table 15. Asia Pacific Autoimmune Disease Diagnostics Market by End User, 2021-2031, USD mn 91

Table 16. APAC Autoimmune Disease Diagnostics Market by Country, 2021-2031, USD mn 98

Table 17. Japan Autoimmune Disease Diagnostics Market by Product, 2021-2031, USD mn 102

Table 18. Japan Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, USD mn 102

Table 19. Japan Autoimmune Disease Diagnostics Market by End User, 2021-2031, USD mn 102

Table 20. China Autoimmune Disease Diagnostics Market by Product, 2021-2031, USD mn 104

Table 21. China Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, USD mn 104

Table 22. China Autoimmune Disease Diagnostics Market by End User, 2021-2031, USD mn 104

Table 23. Australia Autoimmune Disease Diagnostics Market by Product, 2021-2031, USD mn 106

Table 24. Australia Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, USD mn 106

Table 25. Australia Autoimmune Disease Diagnostics Market by End User, 2021-2031, USD mn 106

Table 26. India Autoimmune Disease Diagnostics Market by Product, 2021-2031, USD mn 108

Table 27. India Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, USD mn 108

Table 28. India Autoimmune Disease Diagnostics Market by End User, 2021-2031, USD mn 108

Table 29. South Korea Autoimmune Disease Diagnostics Market by Product, 2021-2031, USD mn 110

Table 30. South Korea Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, USD mn 110

Table 31. South Korea Autoimmune Disease Diagnostics Market by End User, 2021-2031, USD mn 110

Table 32. Autoimmune Disease Diagnostics Market in Rest of APAC by Country/Region, 2021-2031, USD mn 112

Table 33. Abbott Laboratories: Company Snapshot 117

Table 34. Abbott Laboratories: Business Segmentation 118

Table 35. Abbott Laboratories: Product Portfolio 118

Licence Rights

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies


Companies

Selected Key Players:

Abbott Laboratories

Beckman Coulter, Inc.

Biomerieux SA

Bio-rad Laboratories Inc.

F. Hoffmann-la Roche Ltd.

Hemagen Diagnostics Inc.

Myriad Genetics Inc.

PerkinElmer Inc. (Euroimmun AG)

Quest Diagnostics Inc.

Siemens Healthineers Inc.

Thermo Fisher Scientific Inc.

Trinity Biotech PLC

Werfen Company (Inova Diagnostics Inc.)

(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Company Profile

Company Profile Title

Asia Pacific autoimmune disease diagnostics market will grow by 9.7% annually with a total addressable market cap of USD 19.06 billion over 2022-2031 owing to the growing prevalence of autoimmune diseases, the strong investment in research and development activities, the rise in technological advancements, increasing patient awareness and healthcare expenditure, and favorable government policies.

Highlighted with 35 tables and 70 figures, this 131-page report Asia Pacific Autoimmune Disease Diagnostics Market 2021-2031 by Product (Assay Kits & Consumables, Analyzers & Instruments), Test Type (Autoantibodies and Immunologic, Inflammatory Marker, Routine Laboratory, Others), Disease Type (Systemic, Localized), Gender (Female, Male), Age (<44, 44-64, >64), End User (Hospitals, Clinics, Diagnostic Labs), and Country: Trend Forecast and Growth Opportunity is based on a comprehensive research of the entire Asia Pacific autoimmune disease diagnostics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:

Market Structure

Growth Drivers

Restraints and Challenges

Emerging Product Trends & Market Opportunities

Porter's Fiver Forces

The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Asia Pacific autoimmune disease diagnostics market in every aspect of the classification from perspectives of Product, Test Type, Disease Type, Gender, Age, End User, and Country.

Based on Product, the Asia Pacific market is segmented into the following sub-markets with annual revenue (USD mn) for 2021-2031 included in each section.

Assay Kits & Consumables

Analyzers & Instruments

Based on Test Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue (USD mn) for 2021-2031 included in each section.

Autoantibodies and Immunologic Tests

o Antinuclear Antibody Tests

o Anti-cyclic Citrullinated Peptide

o Enzyme-Linked Immunosorbent Assay (ELISA)

o Rheumatoid Factor

o Thyroid Antibody Tests

o Other Autoantibodies and Immunologic Tests

Inflammatory Marker Tests

o C-Reactive Protein (CRP)

o Erythrocyte Sedimentation Rate (ESR)

o Other Inflammatory Marker Tests

Routine Laboratory Tests

o Urinalysis

o Complete Blood Count (CBC) Tests

o Other Routine Laboratory Tests

Other Test Types

Based on Disease Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue (USD mn) for 2021-2031 included in each section.

Systemic Autoimmune Disease

o Rheumatoid Arthritis

o Systemic Lupus Erythematosus (SLE)

o Psoriasis/Psoriatic Arthritis

o Other Systemic Autoimmune Diseases

Localized Autoimmune Disease

o Thyroiditis

o Multiple Sclerosis

o Inflammatory Bowel Disease

o Type 1 Diabetes

o Other Localized Autoimmune Diseases

Based on Gender, the Asia Pacific market is segmented into the following sub-markets with annual revenue (USD mn) for 2021-2031 included in each section.

Female Patients

Male Patients

Based on Age, the Asia Pacific market is segmented into the following sub-markets with annual revenue (USD mn) for 2021-2031 included in each section.

< 44

44 - 64

> 64

Based on End User, the Asia Pacific market is segmented into the following sub-markets with annual revenue (USD mn) for 2021-2031 included in each section.

Hospitals

Clinics

Diagnostic Labs

Other End Users

Geographically, the following national/local markets are fully investigated:

Japan

China

South Korea

Australia

India

Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)

For each key country, detailed analysis and data for annual revenue (USD mn) are available for 2021-2031. The breakdown of the regional market by country and split of key national markets by Product, Disease Type, and End User over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Selected Key Players:

Abbott Laboratories

Beckman Coulter, Inc.

Biomerieux SA

Bio-rad Laboratories Inc.

F. Hoffmann-la Roche Ltd.

Hemagen Diagnostics Inc.

Myriad Genetics Inc.

PerkinElmer Inc. (Euroimmun AG)

Quest Diagnostics Inc.

Siemens Healthineers Inc.

Thermo Fisher Scientific Inc.

Trinity Biotech PLC

Werfen Company (Inova Diagnostics Inc.)

(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

READ MORE

Scope

1 Introduction 8

1.1 Industry Definition and Research Scope 8

1.1.1 Industry Definition 8

1.1.2 Research Scope 9

1.2 Research Methodology 12

1.2.1 Overview of Market Research Methodology 12

1.2.2 Market Assumption 13

1.2.3 Secondary Data 13

1.2.4 Primary Data 13

1.2.5 Data Filtration and Model Design 14

1.2.6 Market Size/Share Estimation 15

1.2.7 Research Limitations 16

1.3 Executive Summary 17

2 Market Overview and Dynamics 20

2.1 Market Size and Forecast 20

2.1.1 Impact of COVID-19 on World Economy 21

2.1.2 Impact of COVID-19 on the Market 23

2.2 Major Growth Drivers 25

2.3 Market Restraints and Challenges 30

2.4 Emerging Opportunities and Market Trends 33

2.5 Porter's Fiver Forces Analysis 37

3 Segmentation of Asia Pacific Market by Product 42

3.1 Market Overview by Product 42

3.2 Assay Kits & Consumables 44

3.3 Analyzers & Instruments 45

4 Segmentation of Asia Pacific Market by Test Type 46

4.1 Market Overview by Test Type 46

4.2 Autoantibodies and Immunologic Tests 48

4.2.1 Antinuclear Antibody Tests 50

4.2.2 Anti-cyclic Citrullinated Peptide 51

4.2.3 Enzyme-Linked Immunosorbent Assay (ELISA) 52

4.2.4 Rheumatoid Factor 53

4.2.5 Thyroid Antibody Tests 54

4.2.6 Other Autoantibodies and Immunologic Tests 55

4.3 Inflammatory Marker Tests 56

4.3.1 C-Reactive Protein (CRP) 58

4.3.2 Erythrocyte Sedimentation Rate (ESR) 59

4.3.3 Other Inflammatory Marker Tests 60

4.4 Routine Laboratory Tests 61

4.4.1 Urinalysis 63

4.4.2 Complete Blood Count (CBC) Tests 64

4.4.3 Other Routine Laboratory Tests 65

4.5 Other Test Types 66

5 Segmentation of Asia Pacific Market by Disease Type 67

5.1 Market Overview by Disease Type 67

5.2 Systemic Autoimmune Disease 69

5.2.1 Rheumatoid Arthritis 71

5.2.2 Systemic Lupus Erythematosus (SLE) 72

5.2.3 Psoriasis/Psoriatic Arthritis 73

5.2.4 Other Systemic Autoimmune Diseases 74

5.3 Localized Autoimmune Disease 75

5.3.1 Thyroiditis 77

5.3.2 Multiple Sclerosis 78

5.3.3 Inflammatory Bowel Disease 79

5.3.4 Type 1 Diabetes 80

5.3.5 Other Localized Autoimmune Diseases 81

6 Segmentation of Asia Pacific Market by Gender 82

6.1 Market Overview by Gender 82

6.2 Female Patients 84

6.3 Male Patients 85

7 Segmentation of Asia Pacific Market by Age 86

7.1 Market Overview by Age 86

7.2 < 44 88

7.3 44 - 64 89

7.4 > 64 90

8 Segmentation of Asia Pacific Market by End User 91

8.1 Market Overview by End User 91

8.2 Hospitals 93

8.3 Clinics 94

8.4 Diagnostic Labs 95

8.5 Other End Users 96

9 Asia-Pacific Market 2021-2031 by Country 97

9.1 Overview of Asia-Pacific Market 97

9.2 Japan 100

9.3 China 103

9.4 Australia 105

9.5 India 107

9.6 South Korea 109

9.7 Rest of APAC Region 111

10 Competitive Landscape 113

10.1 Overview of Key Vendors 113

10.2 New Product Launch, Partnership, Investment, and M&A 116

10.3 Company Profiles 117

Abbott Laboratories 117

Beckman Coulter, Inc. 119

Biomerieux SA 120

Bio-rad Laboratories Inc. 121

F. Hoffmann-la Roche Ltd. 122

Hemagen Diagnostics Inc. 123

Myriad Genetics Inc. 124

PerkinElmer Inc. (Euroimmun AG) 125

Quest Diagnostics Inc. 126

Siemens Healthineers Inc. 127

Thermo Fisher Scientific Inc. 128

Trinity Biotech PLC 129

Werfen Company (Inova Diagnostics Inc.) 130

RELATED REPORTS 131


List Of Figure

List of Figures:

Figure 1. Research Method Flow Chart 12

Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 15

Figure 3. Asia Pacific Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031 17

Figure 4. Asia Pacific Autoimmune Disease Diagnostics Market, 2021-2031, USD mn 20

Figure 5. Impact of COVID-19 on Business 23

Figure 6. Primary Drivers and Impact Factors of Asia Pacific Autoimmune Disease Diagnostics Market 25

Figure 7. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 28

Figure 8. World Population 65 and Over, % of Total Population, 1950-2060 28

Figure 9. Primary Restraints and Impact Factors of Asia Pacific Autoimmune Disease Diagnostics Market 30

Figure 10. Investment Opportunity Analysis 34

Figure 11. Porter's Fiver Forces Analysis of Asia Pacific Autoimmune Disease Diagnostics Market 37

Figure 12. Breakdown of Asia Pacific Autoimmune Disease Diagnostics Market by Product, 2021-2031, % of Revenue 43

Figure 13. Asia Pacific Addressable Market Cap in 2022-2031 by Product, Value (USD mn) and Share (%) 43

Figure 14. Asia Pacific Autoimmune Disease Diagnostics Market by Product: Assay Kits & Consumables, 2021-2031, USD mn 44

Figure 15. Asia Pacific Autoimmune Disease Diagnostics Market by Product: Analyzers & Instruments, 2021-2031, USD mn 45

Figure 16. Breakdown of Asia Pacific Autoimmune Disease Diagnostics Market by Test Type, 2021-2031, % of Sales Revenue 47

Figure 17. Asia Pacific Addressable Market Cap in 2022-2031 by Test Type, Value (USD mn) and Share (%) 47

Figure 18. Asia Pacific Autoimmune Disease Diagnostics Market by Test Type: Autoantibodies and Immunologic Tests, 2021-2031, USD mn 48

Figure 19. Asia Pacific Autoimmune Disease Diagnostics Market by Autoantibodies and Immunologic Tests: Antinuclear Antibody Tests, 2021-2031, USD mn 50

Figure 20. Asia Pacific Autoimmune Disease Diagnostics Market by Autoantibodies and Immunologic Tests: Anti-cyclic Citrullinated Peptide, 2021-2031, USD mn 51

Figure 21. Asia Pacific Autoimmune Disease Diagnostics Market by Autoantibodies and Immunologic Tests: Enzyme-Linked Immunosorbent Assay (ELISA), 2021-2031, USD mn 52

Figure 22. Asia Pacific Autoimmune Disease Diagnostics Market by Autoantibodies and Immunologic Tests: Rheumatoid Factor, 2021-2031, USD mn 53

Figure 23. Asia Pacific Autoimmune Disease Diagnostics Market by Autoantibodies and Immunologic Tests: Thyroid Antibody Tests, 2021-2031, USD mn 54

Figure 24. Asia Pacific Autoimmune Disease Diagnostics Market by Autoantibodies and Immunologic Tests: Other Autoantibodies and Immunologic Tests, 2021-2031, USD mn 55

Figure 25. Asia Pacific Autoimmune Disease Diagnostics Market by Test Type: Inflammatory Marker Tests, 2021-2031, USD mn 56

Figure 26. Asia Pacific Autoimmune Disease Diagnostics Market by Inflammatory Marker Tests: C-Reactive Protein (CRP), 2021-2031, USD mn 58

Figure 27. Asia Pacific Autoimmune Disease Diagnostics Market by Inflammatory Marker Tests: Erythrocyte Sedimentation Rate (ESR), 2021-2031, USD mn 59

Figure 28. Asia Pacific Autoimmune Disease Diagnostics Market by Inflammatory Marker Tests: Other Inflammatory Marker Tests, 2021-2031, USD mn 60

Figure 29. Asia Pacific Autoimmune Disease Diagnostics Market by Test Type: Routine Laboratory Tests, 2021-2031, USD mn 61

Figure 30. Asia Pacific Autoimmune Disease Diagnostics Market by Routine Laboratory Tests: Urinalysis, 2021-2031, USD mn 63

Figure 31. Asia Pacific Autoimmune Disease Diagnostics Market by Routine Laboratory Tests: Complete Blood Count (CBC) Tests, 2021-2031, USD mn 64

Figure 32. Asia Pacific Autoimmune Disease Diagnostics Market by Routine Laboratory Tests: Other Routine Laboratory Tests, 2021-2031, USD mn 65

Figure 33. Asia Pacific Autoimmune Disease Diagnostics Market by Test Type: Other Test Types, 2021-2031, USD mn 66

Figure 34. Breakdown of Asia Pacific Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, % of Sales Revenue 68

Figure 35. Asia Pacific Addressable Market Cap in 2022-2031 by Disease Type, Value (USD mn) and Share (%) 68

Figure 36. Asia Pacific Autoimmune Disease Diagnostics Market by Disease Type: Systemic Autoimmune Disease, 2021-2031, USD mn 69

Figure 37. Asia Pacific Autoimmune Disease Diagnostics Market by Systemic Autoimmune Disease: Rheumatoid Arthritis, 2021-2031, USD mn 71

Figure 38. Asia Pacific Autoimmune Disease Diagnostics Market by Systemic Autoimmune Disease: Systemic Lupus Erythematosus (SLE), 2021-2031, USD mn 72

Figure 39. Asia Pacific Autoimmune Disease Diagnostics Market by Systemic Autoimmune Disease: Psoriasis/Psoriatic Arthritis, 2021-2031, USD mn 73

Figure 40. Asia Pacific Autoimmune Disease Diagnostics Market by Systemic Autoimmune Disease: Other Systemic Autoimmune Diseases, 2021-2031, USD mn 74

Figure 41. Asia Pacific Autoimmune Disease Diagnostics Market by Disease Type: Localized Autoimmune Disease, 2021-2031, USD mn 75

Figure 42. Asia Pacific Autoimmune Disease Diagnostics Market by Localized Autoimmune Disease: Thyroiditis, 2021-2031, USD mn 77

Figure 43. Asia Pacific Autoimmune Disease Diagnostics Market by Localized Autoimmune Disease: Multiple Sclerosis, 2021-2031, USD mn 78

Figure 44. Asia Pacific Autoimmune Disease Diagnostics Market by Localized Autoimmune Disease: Inflammatory Bowel Disease, 2021-2031, USD mn 79

Figure 45. Asia Pacific Autoimmune Disease Diagnostics Market by Localized Autoimmune Disease: Type 1 Diabetes, 2021-2031, USD mn 80

Figure 46. Asia Pacific Autoimmune Disease Diagnostics Market by Localized Autoimmune Disease: Other Localized Autoimmune Diseases, 2021-2031, USD mn 81

Figure 47. Breakdown of Asia Pacific Autoimmune Disease Diagnostics Market by Gender, 2021-2031, % of Revenue 83

Figure 48. Asia Pacific Addressable Market Cap in 2022-2031 by Gender, Value (USD mn) and Share (%) 83

Figure 49. Asia Pacific Autoimmune Disease Diagnostics Market by Gender: Female Patients, 2021-2031, USD mn 84

Figure 50. Asia Pacific Autoimmune Disease Diagnostics Market by Gender: Male Patients, 2021-2031, USD mn 85

Figure 51. Breakdown of Asia Pacific Autoimmune Disease Diagnostics Market by Age, 2021-2031, % of Revenue 87

Figure 52. Asia Pacific Addressable Market Cap in 2022-2031 by Age, Value (USD mn) and Share (%) 87

Figure 53. Asia Pacific Autoimmune Disease Diagnostics Market by Age: < 44, 2021-2031, USD mn 88

Figure 54. Asia Pacific Autoimmune Disease Diagnostics Market by Age: 44 - 64, 2021-2031, USD mn 89

Figure 55. Asia Pacific Autoimmune Disease Diagnostics Market by Age: > 64, 2021-2031, USD mn 90

Figure 56. Breakdown of Asia Pacific Autoimmune Disease Diagnostics Market by End User, 2021-2031, % of Revenue 91

Figure 57. Asia Pacific Addressable Market Cap in 2022-2031 by End User, Value (USD mn) and Share (%) 92

Figure 58. Asia Pacific Autoimmune Disease Diagnostics Market by End User: Hospitals, 2021-2031, USD mn 93

Figure 59. Asia Pacific Autoimmune Disease Diagnostics Market by End User: Clinics, 2021-2031, USD mn 94

Figure 60. Asia Pacific Autoimmune Disease Diagnostics Market by End User: Diagnostic Labs, 2021-2031, USD mn 95

Figure 61. Asia Pacific Autoimmune Disease Diagnostics Market by End User: Other End Users, 2021-2031, USD mn 96

Figure 62. Breakdown of APAC Autoimmune Disease Diagnostics Market by Country, 2021 and 2031, % of Revenue 98

Figure 63. Contribution to APAC 2022-2031 Cumulative Market by Country, Value (USD mn) and Share (%) 99

Figure 64. Autoimmune Disease Diagnostics Market in Japan, 2021-2031, USD mn 101

Figure 65. Autoimmune Disease Diagnostics Market in China, 2021-2031, USD mn 103

Figure 66. Autoimmune Disease Diagnostics Market in Australia, 2021-2031, USD mn 105

Figure 67. Autoimmune Disease Diagnostics Market in India, 2021-2031, USD mn 107

Figure 68. Autoimmune Disease Diagnostics Market in South Korea, 2021-2031, USD mn 109

Figure 69. Autoimmune Disease Diagnostics Market in Rest of APAC, 2021-2031, USD mn 111

Figure 70. Growth Stage of Asia Pacific Autoimmune Disease Diagnostics Industry over the Forecast Period 113


List Of Table

List of Tables:

Table 1. Snapshot of Asia Pacific Autoimmune Disease Diagnostics Market in Balanced Perspective, 2021-2031 18

Table 2. World Economic Outlook, 2021-2031 22

Table 3. World Health Spending by Region, USD bn, 2013-2020 29

Table 4. Main Product Trends and Market Opportunities in Asia Pacific Autoimmune Disease Diagnostics Market 33

Table 5. Asia Pacific Autoimmune Disease Diagnostics Market by Product, 2021-2031, USD mn 42

Table 6. Asia Pacific Autoimmune Disease Diagnostics Market by Test Type, 2021-2031, USD mn 46

Table 7. Asia Pacific Autoimmune Disease Diagnostics Market: Autoantibodies and Immunologic Tests by Type, 2021-2031, USD mn 49

Table 8. Asia Pacific Autoimmune Disease Diagnostics Market: Inflammatory Marker Tests by Type, 2021-2031, USD mn 57

Table 9. Asia Pacific Autoimmune Disease Diagnostics Market: Routine Laboratory Tests by Type, 2021-2031, USD mn 62

Table 10. Asia Pacific Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, USD mn 67

Table 11. Asia Pacific Autoimmune Disease Diagnostics Market: Systemic Autoimmune Disease by Type, 2021-2031, USD mn 70

Table 12. Asia Pacific Autoimmune Disease Diagnostics Market: Localized Autoimmune Disease by Type, 2021-2031, USD mn 76

Table 13. Asia Pacific Autoimmune Disease Diagnostics Market by Gender, 2021-2031, USD mn 82

Table 14. Asia Pacific Autoimmune Disease Diagnostics Market by Age, 2021-2031, USD mn 86

Table 15. Asia Pacific Autoimmune Disease Diagnostics Market by End User, 2021-2031, USD mn 91

Table 16. APAC Autoimmune Disease Diagnostics Market by Country, 2021-2031, USD mn 98

Table 17. Japan Autoimmune Disease Diagnostics Market by Product, 2021-2031, USD mn 102

Table 18. Japan Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, USD mn 102

Table 19. Japan Autoimmune Disease Diagnostics Market by End User, 2021-2031, USD mn 102

Table 20. China Autoimmune Disease Diagnostics Market by Product, 2021-2031, USD mn 104

Table 21. China Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, USD mn 104

Table 22. China Autoimmune Disease Diagnostics Market by End User, 2021-2031, USD mn 104

Table 23. Australia Autoimmune Disease Diagnostics Market by Product, 2021-2031, USD mn 106

Table 24. Australia Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, USD mn 106

Table 25. Australia Autoimmune Disease Diagnostics Market by End User, 2021-2031, USD mn 106

Table 26. India Autoimmune Disease Diagnostics Market by Product, 2021-2031, USD mn 108

Table 27. India Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, USD mn 108

Table 28. India Autoimmune Disease Diagnostics Market by End User, 2021-2031, USD mn 108

Table 29. South Korea Autoimmune Disease Diagnostics Market by Product, 2021-2031, USD mn 110

Table 30. South Korea Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, USD mn 110

Table 31. South Korea Autoimmune Disease Diagnostics Market by End User, 2021-2031, USD mn 110

Table 32. Autoimmune Disease Diagnostics Market in Rest of APAC by Country/Region, 2021-2031, USD mn 112

Table 33. Abbott Laboratories: Company Snapshot 117

Table 34. Abbott Laboratories: Business Segmentation 118

Table 35. Abbott Laboratories: Product Portfolio 118

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS


Companies

Selected Key Players:

Abbott Laboratories

Beckman Coulter, Inc.

Biomerieux SA

Bio-rad Laboratories Inc.

F. Hoffmann-la Roche Ltd.

Hemagen Diagnostics Inc.

Myriad Genetics Inc.

PerkinElmer Inc. (Euroimmun AG)

Quest Diagnostics Inc.

Siemens Healthineers Inc.

Thermo Fisher Scientific Inc.

Trinity Biotech PLC

Werfen Company (Inova Diagnostics Inc.)

(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)